Dual roles for HMGB1: DNA binding and cytokine

Journal of Endotoxin Research

Volumn 7, Issue 4, 2001, Pages 315-321

  Czura, C J ^a   Wang, H ^a   Tracey, K J ^a  

^a North Shore/LIJ Research Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYTOKINE; DNA; DNA BINDING PROTEIN; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BACTEREMIA; BLOOD LEVEL; CAUSE OF DEATH; CONTROLLED STUDY; DNA BINDING; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; DRUG RESEARCH; DRUG SYNTHESIS; DRUG TARGETING; ENDOTOXEMIA; GRAM NEGATIVE BACTERIUM; HOST; HUMAN; INFECTION; INFLAMMATION; LETHALITY; MACROPHAGE; MOUSE; NERVE FIBER GROWTH; NONHUMAN; RAT; SEPSIS;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0034753236     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805101101532792     Document Type: Article

References (79)

1. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function
2. Ancestry and diversity of the HMG box superfamily
3. Homology model building of the HMG-1 box structural domain
4. The HMG-1 box protein family: Classification and functional relationships
5. The HMG-14/-17 chromosomal protein family: Architectural elements that enhance transcription from chromatin templates
6. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination
7. Analysis of HMG-14/-17-containing chromatin
8. Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes
9. Chromosomal proteins HMG-14 and HMG-17 are released from mitotic chromosomes and imported into the nucleus by active transport
10. Clusters of nucleosomes containing chromosomal protein HMG-17 in chromatin
11. Structural features of the HMG chromosomal proteins and their genes
12. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1
13. Sequence of human HMG2 cDNA
14. Mapping of the Hmg1 gene and of seven related sequences in the mouse
15. The active gene that encodes human high mobility group 1 protein (HMG) contains introns and maps to chromosome 13
16. Distribution of high mobility group proteins in different tissues of rats during aging
17. A signature for the HMG-1 box DNA binding proteins
18. Domain structure in high molecular weight high mobility group non-histone chromatin proteins
19. Conformation and domain structure of the non-histone chromosomal proteins, HMG1 and 2; Isolation of two folded fragments from HMG1 and 2
20. Conformation and domain structure of the non-histone chromosomal proteins HMG1 and 2; domain interactions
21. Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I
22. In vitro acetylation of the liver HMG non-histone proteins and its modulation by spermine and dexamethasone during aging of rats
23. Estradiol enhanced acetylation of nuclear high mobility group proteins of the uterus of newborn guinea pigs
24. Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1
25. Role of HMG-nucleosome complexes in eukaryotic gene activity
26. High-mobility group and other non-histone substrates for nuclear histone N-acetyltransferase
27. The DNA binding site in HMG1 proteins is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins
28. Non-histone chromosomal protein HMG1 interactions with DNA. Fluorescence and thermal denaturation studies
29. The DNA-binding protein HMG-1 enhances progesterone receptor binding to its target DNA sequences
30. The specific interactions of HMG1 and 2 with negatively supercoiled DNA are modulated by their acidic C-terminal domains and involve cysteine residues in their HMG 1/2 boxes
31. HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures
32. Coregulatory proteins in steroid hormone receptor action: The role of chromatin high mobility group proteins HMG-1 and -2
33. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells
34. High mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells
35. Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells
36. II30 affect estrogen receptor-mediated transcriptional activation
37. HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation
38. High mobility group protein 1 interacts specifically with the core domain of human TAT box-binding protein and interferes with transcription factor IIB within the pre-initiation complex
39. Enhancement of transcription factor, USF, binding to the adenovirus major late promoter: Effect of dithiothreitol and high mobility group protein-1
40. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors
41. High mobility group protein-1 (HMG-1) is a unique activator of p53
42. Interactions between an HMG-1 protein and members of the Rel family
43. Interaction between domains in chromosomal protein HMG-1
44. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons
45. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth
46. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
47. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin
48. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
49. Receptor for advanced glycation endproducts (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways
50. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
51. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation endproducts
52. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells
53. HMG-1 as a late mediator of endotoxin lethality in mice
54. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes
55. An N-terminal hydrophobic peak is the sorting signal of regulated secretory proteins
56. HMG-1 as a mediator of acute lung inflammatory
57. Secretory products of macrophages
58. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia
59. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
60. Biologic basis for interleukin-1 in disease
61. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1β and interleukin 1α
62. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1
63. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
64. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock
65. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling
66. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
67. Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: Cationic liposomal gene therapy of carcinomatosa
68. Signal transduction pathways activated by CpG-DNA
69. High mobility group proteins 1 and 2 stimulate transcription in vitro by RNA polymerases II and III
70. Effects of high mobility group proteins 1 and 2 on initiation and elongation of specific transcription by RNA polymerase II in vitro
71. High mobility group proteins 1 and 2 function as general class II transcription factors
72. The high mobility group protein HMG1 can reversibly inhibit class II gene transcription by interaction with the TATA-binding protein
73. Amphoterin (P30, HMG-1) and RIP are early markers of oligodendrocytes in the developing rat spinal cord
74. Regulation of cell migration by amphoterin
75. Plasminogen activator release at the neuronal growth cone
76. Normal and malignant cells, including neurons, deposit plasminogen activator on the growth substrata
77. Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation